AI in Healthcare Blogs

Companies like Atomwise, Exscientia, InSilico Medicine, Insitro, HealX and Cyclica have been pursuing partnerships with big pharma along with the development of their own compounds. There are two main business models that we’re starting to see here. First, there’s the … Read More

Biological processes are complex, and that means that they lead to multi-dimensional data that human beings struggle to wrap their heads around. The good news is that AI is the perfect tool to spot patterns in this kind of data, … Read More

Built on language models, artificial intelligence-powered generators such as ChatGPT can be made to read the codes that make up the building blocks of the human body. Research has found that it’s possible to develop a generalizable program—a “genomic language … Read More

THE CALIFORNIA BIOMEDICAL RESEARCH ASSOCIATION says that it currently takes an average of 12 years for a drug in the US to go from the research lab to the patient. Only one in every thousand drugs that begins pre-clinical testing … Read More

One of the major benefits of AI-enabled healthcare solutions is that they provide a higher degree of personalization. As such, they could be a wise choice in the emerging direct-to-consumer health market.   Companies are selling products that are meant … Read More

While we’ve examined the issues that are keeping the majority of buyers from immediately adopting healthcare AI solutions, there are still pockets of potential buyers who could become the early adopters. These buyers can see an immediate ROI and don’t … Read More

If you work for an innovative company with an FDA-approved healthcare AI solution, it can be a shock when you realize that no one is lining up to buy your well-designed and full-of-value product. But there are no shortcuts, and … Read More

In my discussions with leaders at cutting edge companies with FDA-approved products in healthcare AI, I’ve noticed a common thread. Most were surprised by how difficult it’s been to successfully sell FDA-approved solutions in radiology, pathology, ophthalmology, and more. They … Read More

Given all of the complexities we discussed for the investors as they evaluate health AI solutions, you think there’s plenty to worry about already for potential investors. Well, maybe!  Another issue that I think the investors should keep in mind … Read More

If you are an investor in this space, how do you evaluate the defensibility of the products, services, or the business model of a prospective health AI company?  patents? copyrights? data?  Given that many entities have access to large datasets … Read More